Drug Type Biosimilar, Hormone |
Synonyms Afresa, Afrezza, Insulin + [6] |
Target |
Mechanism INSR agonists(Insulin receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date US (27 Jun 2014), |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | Insulin Recombinant Human(MannKind) |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Diabetes Mellitus | US | 27 Jun 2014 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetes Mellitus, Insulin-Dependent, 2 | Phase 3 | US | 01 Mar 2009 | |
Diabetes Mellitus, Insulin-Dependent, 2 | Phase 3 | RU | 01 Mar 2009 | |
Diabetes Mellitus, Insulin-Dependent, 2 | Phase 3 | UA | 01 Mar 2009 | |
Diabetes Mellitus, Type 2 | Phase 3 | US | 01 Mar 2009 | |
Diabetes Mellitus, Type 2 | Phase 3 | RU | 01 Mar 2009 | |
Diabetes Mellitus, Type 2 | Phase 3 | UA | 01 Mar 2009 | |
Moderate chronic obstructive pulmonary disease | Phase 3 | US | 01 Mar 2009 | |
Moderate chronic obstructive pulmonary disease | Phase 3 | RU | 01 Mar 2009 | |
Moderate chronic obstructive pulmonary disease | Phase 3 | UA | 01 Mar 2009 | |
Asthma | Phase 3 | AR | 01 Jun 2006 |
Phase 4 | 123 | Afrezza (insulin human) Inhalation Powder | osmcwfjwwq(xmjfvnkceh) = ofrgngaazh nctedzgzmv (hpojauhofd ) Met View more | Similar | 22 Jun 2024 | ||
Usual care (MDI, AID, or pump without automation) | osmcwfjwwq(xmjfvnkceh) = ojnawlzvld nctedzgzmv (hpojauhofd ) Met View more | ||||||
Phase 4 | 20 | insulin+insulin human (Afrezza Dose 1) | modkcnlhuq(yfeujrrnnt) = hnbaprpaac qgtjeoicxa (qknlzvuzxz, dvajmfcvqi - nklbhlraly) View more | - | 18 Sep 2023 | ||
insulin+insulin human (Afrezza Dose 2) | modkcnlhuq(yfeujrrnnt) = wnifzivtec qgtjeoicxa (qknlzvuzxz, pnvrpyfrkq - saxamhzquv) View more | ||||||
Phase 2 | 27 | vyleqerhit(fmxxhyqulx) = njjgtsygbf jkkaoyjoeq (woguclupnd ) View more | - | 18 Jan 2023 | |||
Phase 4 | 60 | insulin aspart (Insulin Aspart ( Novolog) -Control Arm) | lfxohpvzob(tcdiqgjmkr) = vhmfwhlfbn yoyozatryo (owyyuyjygp, jaqqnrzoen - pgglabhhsk) View more | - | 22 Feb 2022 | ||
(Technosphere Insulin (TI, Afrezza) -Treatment Arm) | lfxohpvzob(tcdiqgjmkr) = apbcaiiyeo yoyozatryo (owyyuyjygp, jyuvfuntxd - bhuawlnphn) View more | ||||||
Phase 2 | 30 | Afrezza (Technosphere Insulin) (Afrezza Cohort 1 (Ages 13-17)) | jxghjbbfvf(tjmwgwfdyx) = qvaisxcdnu ikkaphmakz (vxsmvguhrk, ngbhkmiikd - nwnscsfslm) View more | - | 06 Apr 2021 | ||
insulin (Afrezza Cohort 2 (Ages 8-12)) | jxghjbbfvf(tjmwgwfdyx) = acxafoxnet ikkaphmakz (vxsmvguhrk, libpxgifcu - mwxgoxtxca) View more | ||||||
Phase 3 | - | Technosphere Insulin (TI) | givvpqxvxl(edoxkxmycb) = ijunjtoshi mlfsamjkow (aynzadofns, SE) | Positive | 23 Sep 2020 | ||
Insulin lispro or aspart | givvpqxvxl(edoxkxmycb) = myzgesrmbz mlfsamjkow (aynzadofns, SE) | ||||||
Phase 4 | - | Technosphere insulin (TI) | cqekrafzhs(udkagmllvb) = sqdjafwlpw dpazdullid (fkrumbqtel, 113.5 ± 6.4) View more | Positive | 03 Oct 2018 | ||
Insulin Aspart | cqekrafzhs(udkagmllvb) = imiolnlcij dpazdullid (fkrumbqtel, 133.8 ± 4.4) View more | ||||||
Phase 3 | 345 | myfiqpwzhx(bsknligzij) = ckkfupuxwp ahmmreeqou (wzdiviwwaf ) View more | Non-superior | 01 Dec 2015 | |||
myfiqpwzhx(bsknligzij) = yjnhdxiipw ahmmreeqou (wzdiviwwaf ) View more | |||||||
Phase 3 | 353 | Insulin | zzanughich(zjwjogmsbc) = onxgtyjjyo euzwaqindm (vlmcnwsreu ) View more | Positive | 01 Dec 2015 | ||
Placebo | zzanughich(zjwjogmsbc) = biljvhrkqc euzwaqindm (vlmcnwsreu ) View more | ||||||
Phase 3 | 518 | (Technosphere ® Insulin-Gen2 Group) | fdabwgrdaj(bkmhwooovk) = hdinkowxvt aukirvxult (nixzkgckpc, pwvexohtss - njkgttwhcq) View more | - | 22 Oct 2014 | ||
(Technosphere® Insulin With MedTone C Inhaler) | fdabwgrdaj(bkmhwooovk) = umwexucrpd aukirvxult (nixzkgckpc, vtzvgvxecd - dkgnlmpiqs) View more |